$BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
XNAS
$5.52
▼-18.28%-$1.23
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is BBOT down today? It is at $5.52 (-18.28%), and our scanner flagged it 42 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BBOT spikes, and full due diligence on BBOT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BBOT 42 times in the last 30 days. Create a free account to track $BBOT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
BBOT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 12 unusual-volume and momentum alerts on BBOT today, peaking at 16.7x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystBBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant CancersReported BBO-8520 plus pembrolizumab demonstrated a 75% ORR at 500 mg QD andReported 53% ORR across dose levels in 2L+ KRASG12C inhibitor-experienced NSCLC patientsReported 2L+ KRASG12C inhibitor-naïve NSCLC with ORR of 63% (26/41), disease control rate (DCR) of 100% (41/41) and no grade 3 liver enzyme elevations, from an SEC filing. Read it →Latest filingEFFECTRegistration declared effectiveSep 9, 2026 · yesterdayAcross every filing on file, supply equal to 4319.4% of the tradeable float is in play - 1772.8% has already been sold, and 2546.6% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent share offering + active shelf on file — the company raised capital and can raise more
63,054,549 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Chen Bihua Director | Sold (automatic/other) | -4.53M 5.6% of company | n/a | n/a | n/a | Jul 1, 26 |
Chen Bihua Director | Acquired (grant/award) | +4.53M 5.6% of company | added 34% | 17.88M | n/a | Jul 1, 26 |
Ben Yong Officer | Sold (automatic/other) | -1K | sold 2.3% | 45K | $8K at $7.80 | Jul 1, 26 |
Beltran Pedro Officer | Sold (automatic/other) | -1K | sold 2.3% | 45K | $8K at $7.80 | Jul 1, 26 |
Elmelech Idan Officer | Sold (automatic/other) | -343 | sold 2.3% | 14K | $3K at $7.80 | Jul 1, 26 |
Cobo Marc Officer | Sold (automatic/other) | -125 | sold 2.3% | 5K | $975 at $7.80 | Jul 1, 26 |
Mehra Uneek Other | Sold (automatic/other) | -524 | sold 2.2% | 23K | $5K at $9.03 | Apr 1, 26 |
Beltran Pedro Officer | Sold (automatic/other) | -1K | sold 2.2% | 46K | $9K at $9.03 | Apr 1, 26 |
Ben Yong Officer | Sold (automatic/other) | -1K | sold 2.2% | 46K | $9K at $9.03 | Apr 1, 26 |
Ben Yong Officer | Acquired (grant/award) | +47K 0.06% of company | n/a | 47K | n/a | Mar 10, 26 |
Beltran Pedro Officer | Acquired (grant/award) | +47K 0.06% of company | n/a | 47K | n/a | Mar 10, 26 |
Mehra Uneek Officer | Acquired (grant/award) | +23K 0.03% of company | n/a | 23K | n/a | Mar 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
BBOT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 12 unusual-volume and momentum alerts on BBOT today, peaking at 16.7x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
BBOT last traded at $5.52, down 18.28% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The BBOT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BBOT 42 times in the last 30 days.
BBOT (BridgeBio Oncology Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $710M.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BBOT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BBOT discussion
Sign in to ask a question or join the discussion.